{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:31:38Z","timestamp":1791556298635,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.semarthrit.2025.152762","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T21:37:12Z","timestamp":1749159432000},"page":"152762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["AA amyloidosis in inflammatory joint diseases: A systematic review"],"prefix":"10.1016","volume":"74","author":[{"given":"Binta","family":"SAVADOGO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"FAHED","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"SELLAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"GEORGIN-LAVIALLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"FAUTREL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5244-7881","authenticated-orcid":false,"given":"St\u00e9phane","family":"MITROVIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2025.152762_bib0001","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0002","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/rheumatology\/38.6.499","article-title":"Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland","volume":"38","author":"Myllykangas-Luosujarvi","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0003","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jbspin.2008.08.009","article-title":"Prevalence of subclinical amyloidosis in Tunisian patients with rheumatoid arthritis","volume":"76","author":"Younes","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0004","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10067-010-1469-4","article-title":"Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis","volume":"29","author":"Nakamura","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejim.2020.08.012","article-title":"Cause of death and risk factors for mortality in AA amyloidosis: a French retrospective study","volume":"82","author":"Terr\u00e9","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0006","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.revmed.2022.12.004","article-title":"French practical guidelines for the diagnosis and management of AA amyloidosis","volume":"44","author":"Georgin-Lavialle","year":"2023","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0007","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2169\/internalmedicine.42.800","article-title":"Abdominal fat aspiration biopsy and genotyping of serum amyloid a contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis","volume":"42","author":"Ishii","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0008","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.56.9.535","article-title":"Intractable diarrhoea associated with secondary amyloidosis in rheumatoid arthritis","volume":"56","author":"Okuda","year":"1997","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0009","doi-asserted-by":"crossref","unstructured":"Obana M., Matsuoka Y., Fukuda J. - With particular reference to nephropathy. 1990;29:9.","DOI":"10.2169\/internalmedicine1962.29.274"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0010","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00296-012-2646-3","article-title":"Secondary amyloidosis in ankylosing spondylitis","volume":"33","author":"D\u00f6nmez","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0011","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/13506129.2011.574354078","article-title":"Do inflammatory rheumatic diseases still cause as much harm through amyloidosis?","volume":"18","author":"Hunter","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0012","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13506129.2017.1342235","article-title":"Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre","volume":"24","author":"Lane","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/annrheumdis-2024-eular.2310","article-title":"OP0323 causes of AA amyloidosis: Analysis of 952 patients seen at a reference centre over 34 years","volume":"83","author":"Lachmann","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"The PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evidence Based Medicine"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2024-225853","article-title":"Systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR\/PReS recommendations for the diagnosis and management of Still\u2019s disease","author":"De Matteis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0017","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semarthrit.2019.08.005","article-title":"AA amyloidosis secondary to adult onset Still\u2019s disease: about 19 cases","volume":"50","author":"Delplanque","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0018","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/biom8040136","article-title":"Rituximab therapy in renal amyloidosis secondary to rheumatoid arthritis","volume":"8","author":"Kilic","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0019","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/ard.22.4.256","article-title":"Amyloidosis in Rheumatoid Arthritis: Investigated by means of rectal biopsy","volume":"22","author":"Arapakis","year":"1963","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4103\/1319-2442.229291","article-title":"Renal amyloidosis in ankylosing spondylitis: a monocentric study and review of literature","volume":"29","author":"Barbouch","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0021","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/rheumatology\/40.7.821","article-title":"Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide","volume":"40","author":"Chevrel","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0022","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/ard.21.3.298","article-title":"Amyloidosis in rheumatoid arthritis treated with hormones","volume":"21","author":"Gardner","year":"1962","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0023","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/rheumatology\/11.2.78","article-title":"Amyloidosis in ankylosing spondylitis","volume":"11","author":"Jayson","year":"1971","journal-title":"Rheum. Phys. Med."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0024","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/rheumatology\/35.1.44","article-title":"Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy","volume":"35","author":"Kobayashi","year":"1996","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0025","first-page":"948","article-title":"Prevalence of secondary amyloidosis in asian north indian patients with rheumatoid arthritis","volume":"30","author":"Wakhlu","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0026","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3899\/jrheum.090101","article-title":"Effective anti-TNF-\u03b1 therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis","volume":"36","author":"Kuroda","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0027","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/rheumatology\/kes190","article-title":"Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis","volume":"51","author":"Nakamura","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0028","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2169\/internalmedicine.55.6941","article-title":"Effects of biologic agents in patients with rheumatoid arthritis and amyloidosis treated with hemodialysis","volume":"55","author":"Kuroda","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0029","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.amjmed.2009.11.010","article-title":"Long-term TNF-\u03b1 blockade in patients with amyloid a amyloidosis complicating rheumatic diseases","volume":"123","author":"Fern\u00e1ndez-Nebro","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0030","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","article-title":"Anti\u2013tumor necrosis factor \u03b1 therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2023-225114","article-title":"bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease","author":"Kvacskay","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0032","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/13506129.2014.1002031","article-title":"AA amyloidosis treated with tocilizumab: case series and updated literature review","volume":"22","author":"Courties","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0033","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/art.1780391016","article-title":"High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis","volume":"39","author":"Hasegawa","year":"1996","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0034","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/1529-0131(200106)44:6<1266::AID-ART218>3.0.CO;2-3","article-title":"A novel single-nucleotide polymorphism at the 5?-flanking region ofSAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis","volume":"44","author":"Moriguchi","year":"2001","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/rheumatology\/kei112","article-title":"Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis","volume":"45","author":"Nakamura","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506129.2014.980942","article-title":"Risk factors for AA amyloidosis in Germany","volume":"22","author":"Blank","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0037","first-page":"1482","article-title":"Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis","volume":"33","author":"Uda","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0038","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/rheumatology\/keab633","article-title":"The risk, predictors and outcomes of amyloidosis in ankylosing spondylitis: a longitudinal population-based cohort study","volume":"61","author":"Kridin","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0039","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.1700710124","article-title":"Amyloidosis in rheumatoid arthritis","volume":"71","author":"Missen","year":"1956","journal-title":"J Pathol"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10067-003-0842-y","article-title":"The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis","volume":"23","author":"Wojtala","year":"2004","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0041","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/PL00011217","article-title":"Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis","volume":"21","author":"Kuroda","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0042","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.medcle.2016.02.045","article-title":"Amyloidosis complicating spondyloarthropathies: study of 15 cases","volume":"145","author":"Rodr\u00edguez-Muguruza","year":"2015","journal-title":"Medicina Cl\u00ednica (English Edition)"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0043","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/ard.45.8.663","article-title":"Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis","volume":"45","author":"Laakso","year":"1986","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0044","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00296-006-0225-1","article-title":"Role of amyloidosis in determining the prognosis of dialyzed patients with rheumatoid arthritis","volume":"27","author":"Sanai","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02200997","article-title":"Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency","volume":"6","author":"Ahlmen","year":"1987","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0046","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/ard.46.10.757","article-title":"Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease","volume":"46","author":"Berglund","year":"1987","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0047","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3899\/jrheum.111453","article-title":"Treatment with Biologic Agents Improves the Prognosis of Patients with Rheumatoid Arthritis and Amyloidosis","volume":"39","author":"Kuroda","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152762_bib0048","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10067-003-0763-9","article-title":"Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis","volume":"22","author":"Nakamura","year":"2003","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.semarthrit.2025.152762_bib0049","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjmed.2005.01.028","article-title":"Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists","volume":"118","author":"Fern\u00e1ndez-Nebro","year":"2005","journal-title":"Am. J. Med."}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:57:38Z","timestamp":1780120658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":49,"alternative-id":["S0049017225001337"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152762","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AA amyloidosis in inflammatory joint diseases: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152762"}}